1. • Craniopharyngiomas usually arise along the pituitary stalk in
the suprasellar region adjacent to the optic chiasm. A small
percentage arises within the sella [8,9], and even fewer along
the optic system or within the third ventricle [
2. Adamantinomatous craniopharyngiomas are characterized by activation of the
Wnt signaling pathway, and almost all harbor activating mutations
in CTNNB1, the gene encoding β-catenin [13-15]. By contrast, papillary
craniopharyngiomas commonly harbor mutations in the BRAF oncogene
Headache – Moderate to severe daily headaches are present in
approximately 50 percent of patients at the time of diagnosis [20]. These
may result from traction on pain-sensitive structures by the tumor itself,
obstructive hydrocephalus from tumor compression of the third
ventricle, or meningeal irritation by escaped cyst contents.
3. • Calcification in the suprasellar region is seen in 60 to 80 percent
of patients with craniopharyngioma, and one or more cysts are
present in approximately 75 percent. A cystic calcified parasellar
lesion is very likely to be a craniopharyngioma (image
1 and image 2). CT or plain skull radiographs can help
distinguish adamantinomatous craniopharyngiomas from
noncalcified suprasellar lesions. Papillary craniopharyngiomas
frequently lack calcification
4. • • General features ○ Multilobulated, often large (> 5 cm) ○
Occasionally giant, multicompartmental • CT ○ Cystic (90%), Ca++
(90%), enhancing (90%) • MR: Signal varies with cyst contents ○ Cysts
variably hyperintense on T1WI and T2WI ○ Solid portions enhance
heterogeneously; cyst walls enhance strongly ○ Cyst contents show
broad lipid peak (0.9-1.5 ppm) on MR spectroscopy
5. • • Location ○ Surgical division of CPs into 3 groups – Sellar –
Prechiasmatic – Retrochiasmatic ○ Imaging locations of CPs
(adamantinomatous type) – Suprasellar (75%) – Suprasellar +
intrasellar component (21%) – Entirely intrasellar (4%) – Often
extends into multiple cranial fossae: Anterior (30%), middle (23%),
posterior, &/or retroclival (20%